HOME >> BIOLOGY >> NEWS
Urine test may help monitor disfiguring birthmarks

Vascular anomalies birthmarks caused by abnormal development of arteries, capillaries, veins or lymph vessels can sometimes begin to progress, requiring aggressive treatment to save the child's health or vision. Research at Children's Hospital Boston now suggests that urine testing can help monitor these anomalies and predict those about to become a serious threat. The findings, published in the July Pediatrics, also raise the possibility of new drug treatments for aggressive cases, particularly for hard-to-treat vascular malformations.

Vascular anomalies include both vascular malformations and vascular tumors (most commonly hemangiomas). Hemangiomas, found in about 10% of infants, occur when the cells lining blood vessels multiply abnormally, forming clusters of vessels. Hemangiomas grow rapidly in the first year of life, then usually shrink and disappear. But some grow quite large, causing obstruction, ulceration and other problems. Vascular malformations occur during fetal development and include lymphatic, venous, arteriovenous and capillary malformations. They usually grow in proportion to the child, but sometimes progress during adolescence or pregnancy, or after surgery or trauma, in rare instances becoming fatal. There are currently no effective drug treatments.

Marsha Moses, PhD of Children's Vascular Biology Program, senior investigator on the study, had been studying the matrix metalloproteinases (MMPs), a family of enzymes required for angiogenesis, or growth of new blood vessels. Angiogenesis is critical to a cancer's expansion, and Moses' lab was the first to show that inhibitors of MMP can inhibit angiogenesis. Recently, her lab also demonstrated that cancer patients have elevated levels of MMPs in their urine. Because vascular anomalies like hemangiomas also involve angiogenesis, Moses was approached by Jennifer Marler, MD, a fellow in the laboratory of Judah Folkman, MD, at Children's Hospital Boston and a clinical fellow in Child
'"/>

Contact: Elizabeth Andrews
elizabeth.andrews@childrens.harvard.edu
617-355-6420
Children's Hospital Boston
5-Jul-2005


Page: 1 2 3

Related biology news :

1. Urine collected and purified separately
2. Urine helps infectious yeast stick
3. Urine testing might prove to be an alternative screening test for cervical cancer
4. Who needs environmental monitoring?
5. DNA repair proteins monitored at double-strand break
6. Marine scientists monitor longest mammal migration
7. Snowmelt monitored in the Baltic Sea watershed region in near real time
8. Want to monitor climate change? P-p-p-pick up a penguin!
9. Researchers urge monitoring of bone health during chemotherapy
10. New study shows promise of toxicogenomics in environmental monitoring
11. CellSearch System cleared for monitoring metastatic breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/6/2019)... ... 2019 , ... Rigaku Corporation , a global leader ... & Microanalysis 2019 Meeting ( M&M 2019 ), taking place August 4 - ... & Microanalysis Meeting, organized by the Microscopy Society of America, is the world’s ...
(Date:8/4/2019)... ... August 02, 2019 , ... Stay on top of current ... and food industries. Access to all webinars is free, so be sure to register ... field! , Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL OPERATIONS ...
(Date:8/1/2019)... ... August 01, 2019 , ... The GENSPEED platform is a compact, fast ... is fully developed with over 100 units deployed in the field for multiple applications. ... our collaboration with axiVEND will give us a foothold in the USA to better ...
Breaking Biology News(10 mins):
(Date:8/14/2019)... , ... August 13, 2019 , ... ... and in vitro toxicology testing solutions, announced the appointment of Mark McLoughlin to ... to the Board. , Mark McLoughlin will lend his healthcare expertise and extensive ...
(Date:8/6/2019)... , ... August 06, 2019 , ... ... for characterizing microbiome populations down to the strain level, has announced partnerships with ... and other products to companies and research organizations in Australia, Benelux, Indonesia, Korea, ...
(Date:7/26/2019)... ... 2019 , ... LeadingBiotech , an exclusive event series ... Boston BD conference to be held on September 10, 2019, at ... the event provides an opportunity for attendees to leverage insight from real-life business ...
(Date:7/17/2019)... ... July 16, 2019 , ... ... manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for spinal ... have dedicated manufacturing space at the new, state-of-the-art commercial manufacturing center near ...
Breaking Biology Technology:
Cached News: